
Solibite ODG 5mg Tablet
Marketer
Corona Remedies Pvt Ltd
Salt Composition
Solifenacin (5mg)
Overview Solibite ODG 5mg Tablet
Oxybutynin 5mg Orodispersible Tablet is a medication that blocks muscarinic receptors, employed to manage overactive bladder symptoms. It alleviates urinary frequency, urgency, and incontinence. Adhere strictly to your physician's prescribed dosage and regimen. This medication can be ingested with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinuing treatment prematurely may worsen symptoms; complete the prescribed course for optimal results. Potential side effects include dry mouth, constipation, nausea, and urinary tract infections. Increasing fluid intake may help mitigate these effects. Drowsiness or blurred vision may occur; avoid driving if affected. Prior to commencing treatment, disclose all other medications and pre-existing health conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require careful monitoring and regular check-ups under medical supervision.
Uses of Solibite ODG 5mg Tablet
Managing overactive bladder (OAB) symptoms
Major Benefits of Solibite ODG 5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Solibite ODG 5mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Solibite ODG 5mg Tablet:
- Dryness in mouth
- Constipation
- Blurred vision
- Nausea
- Upset stomach
- Urinary tract infection
How to use Solibite ODG 5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Solibite ODG 5mg Tablets can be consumed with or without food; however, consistent timing is recommended for optimal efficacy.
How Solibite ODG 5mg Tablet works:
Solibite ODG 5mg tablets are an antimuscarinic medication. Their action involves relaxing bladder muscles, thereby reducing urinary frequency, urgency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Solibite ODG 5mg tablets with alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Solibite ODG 5mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Solibite ODG 5mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant. However, prolonged use of Solibite ODG 5mg tablets may decrease breast milk supply and potentially lead to constipation, xerostomia, and urinary tract infections in the baby.
DrivingUNSAFE
Driving ability may be impaired by Solibite ODG 5mg Tablet, a medication that can induce side effects such as blurred vision, drowsiness, and fatigue.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Solibite ODG 5mg tablets, as dose modification may be necessary. Physician consultation is advised. Solibite ODG 5mg tablets are unsuitable for individuals undergoing renal dialysis.
LiverCAUTION
Patients with liver impairment should exercise caution when using Solibite ODG 5mg tablets; dosage modification may be necessary. Consult your physician. Solibite ODG 5mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Solibite ODG 5mg Tablet :
Should you forget a Solibite ODG 5mg Tablet dose, administer it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Solibite ODG 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Tetrahydroisoquinoline-Quinuclidine Hybrid |
| Developing Habits | No. |
| Treatment Category | Urological Care |
| Actions | M3 Muscarinic Receptor Antagonist (Bladder-Specific) |
